Barinthus Biotherapeutics plc (BRNS)

Barinthus Biotherapeutics Statistics

Total Valuation

BRNS has a market cap or net worth of $24.51 million. The enterprise value is -$34.67 million.

Market Cap	24.51M
Enterprise Value	-34.67M

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026, before market open.

Earnings Date	May 6, 2026
Ex-Dividend Date	n/a

Share Statistics

BRNS has 40.85 million shares outstanding. The number of shares has increased by 3.00% in one year.

Current Share Class	n/a
Shares Outstanding	40.85M
Shares Change (YoY)	+3.00%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	11.74%
Owned by Institutions (%)	21.01%
Float	36.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.33
P/TBV Ratio	0.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.77, with a Debt / Equity ratio of 0.15.

Current Ratio	7.77
Quick Ratio	7.16
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,138.59

Financial Efficiency

Return on equity (ROE) is -65.02% and return on invested capital (ROIC) is -31.88%.

Return on Equity (ROE)	-65.02%
Return on Assets (ROA)	-28.08%
Return on Invested Capital (ROIC)	-31.88%
Return on Capital Employed (ROCE)	-65.87%
Weighted Average Cost of Capital (WACC)	0.75%
Revenue Per Employee	n/a
Profits Per Employee	-$4.74M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-175,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.44% in the last 52 weeks. The beta is -0.60, so BRNS's price volatility has been lower than the market average.

Beta (5Y)	-0.60
52-Week Price Change	-25.44%
50-Day Moving Average	0.64
200-Day Moving Average	0.97
Relative Strength Index (RSI)	50.16
Average Volume (20 Days)	33,825

Short Selling Information

The latest short interest is 5,208, so 0.02% of the outstanding shares have been sold short.

Short Interest	5,208
Short Previous Month	8,036
Short % of Shares Out	0.02%
Short % of Float	n/a
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	-133,000
Operating Income	-58.07M
Pretax Income	-66.63M
Net Income	-66.43M
EBITDA	-55.22M
EBIT	-58.07M
Earnings Per Share (EPS)	-$1.64

Balance Sheet

The company has $70.46 million in cash and $11.28 million in debt, with a net cash position of $59.18 million or $1.45 per share.

Cash & Cash Equivalents	70.46M
Total Debt	11.28M
Net Cash	59.18M
Net Cash Per Share	$1.45
Equity (Book Value)	74.29M
Book Value Per Share	1.82
Working Capital	67.77M

Cash Flow

In the last 12 months, operating cash flow was -$47.98 million and capital expenditures -$37,000, giving a free cash flow of -$48.02 million.

Operating Cash Flow	-47.98M
Capital Expenditures	-37,000
Depreciation & Amortization	2.85M
Net Borrowing	n/a
Free Cash Flow	-48.02M
FCF Per Share	-$1.18

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BRNS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.00%
Shareholder Yield	-3.00%
Earnings Yield	-271.03%
FCF Yield	-195.91%

Analyst Forecast

The average price target for BRNS is $4.00, which is 566.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.00
Price Target Difference	566.67%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1